INDOCO Stock Overview
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
Indoco Remedies Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹328.65 |
52 Week High | ₹415.00 |
52 Week Low | ₹306.40 |
Beta | 0.43 |
1 Month Change | -9.04% |
3 Month Change | -16.84% |
1 Year Change | 1.22% |
3 Year Change | 14.02% |
5 Year Change | 59.58% |
Change since IPO | 525.21% |
Recent News & Updates
Recent updates
Earnings Miss: Indoco Remedies Limited Missed EPS By 56% And Analysts Are Revising Their Forecasts
Jan 26Does Indoco Remedies (NSE:INDOCO) Have A Healthy Balance Sheet?
Jan 26We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Indoco Remedies Limited's (NSE:INDOCO) CEO For Now
Sep 16Here's Why Indoco Remedies (NSE:INDOCO) Can Manage Its Debt Responsibly
May 21Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50
Aug 31Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50
Jul 04Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?
Jul 02Indoco Remedies (NSE:INDOCO) Seems To Use Debt Quite Sensibly
Jun 10Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?
Mar 25Indoco Remedies Limited's (NSE:INDOCO) Intrinsic Value Is Potentially 21% Below Its Share Price
Mar 09What Percentage Of Indoco Remedies Limited (NSE:INDOCO) Shares Do Insiders Own?
Feb 22Did You Miss Indoco Remedies' (NSE:INDOCO) 37% Share Price Gain?
Feb 07Indoco Remedies Limited's (NSE:INDOCO) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 17Is Indoco Remedies (NSE:INDOCO) A Risky Investment?
Dec 27Calculating The Intrinsic Value Of Indoco Remedies Limited (NSE:INDOCO)
Dec 06What Type Of Shareholders Own The Most Number of Indoco Remedies Limited (NSE:INDOCO) Shares?
Nov 14Investors Who Bought Indoco Remedies (NSE:INDOCO) Shares A Year Ago Are Now Up 66%
Oct 19These 4 Measures Indicate That Indoco Remedies (NSE:INDOCO) Is Using Debt Reasonably Well
Sep 14Indoco Remedies Limited (NSE:INDOCO) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Aug 17How Much Did Indoco Remedies'(NSE:INDOCO) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jul 19Shareholder Returns
INDOCO | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -2.3% | 2.4% | 1.8% |
1Y | 1.2% | 65.8% | 48.6% |
Return vs Industry: INDOCO underperformed the Indian Pharmaceuticals industry which returned 63.9% over the past year.
Return vs Market: INDOCO underperformed the Indian Market which returned 47.3% over the past year.
Price Volatility
INDOCO volatility | |
---|---|
INDOCO Average Weekly Movement | 5.2% |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 6.6% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: INDOCO has not had significant price volatility in the past 3 months.
Volatility Over Time: INDOCO's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1945 | 6,000 | Sundeep Bambolkar | https://www.indoco.com |
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infective, vitamin/mineral/nutrient, ophthal/ontological, antifungal, hormonal, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; anti-haemorrhoidals; antacids; antihistaminic; etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services.
Indoco Remedies Limited Fundamentals Summary
INDOCO fundamental statistics | |
---|---|
Market cap | ₹30.29b |
Earnings (TTM) | ₹1.02b |
Revenue (TTM) | ₹17.96b |
29.8x
P/E Ratio1.7x
P/S RatioIs INDOCO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
INDOCO income statement (TTM) | |
---|---|
Revenue | ₹17.96b |
Cost of Revenue | ₹5.95b |
Gross Profit | ₹12.01b |
Other Expenses | ₹11.00b |
Earnings | ₹1.02b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 11.02 |
Gross Margin | 66.89% |
Net Profit Margin | 5.66% |
Debt/Equity Ratio | 46.3% |
How did INDOCO perform over the long term?
See historical performance and comparison